BLM and cancer: Although all defects caused by hypomorphic BLM variants were significantly less pronounced than in Bloom syndrome cells, any increased mutation load over a person's lifetime is likely to be associated with increased cancer risk; this risk is known to be extraordinarily high for BLM null alleles, leading to Bloom syndrome, and now remains to be defined for the newly identified class of hypomorphic BLM variants, currently represented by R791C, P868L, and G1120R.